...
首页> 外文期刊>Biochemical and Biophysical Research Communications >Reactive oxygen species regulate Pseudomonas aeruginosa lipopolysaccharide-induced MUC5AC mucin expression via PKC-NADPH oxidase-ROS-TGF-alpha signaling pathways in human airway epithelial cells
【24h】

Reactive oxygen species regulate Pseudomonas aeruginosa lipopolysaccharide-induced MUC5AC mucin expression via PKC-NADPH oxidase-ROS-TGF-alpha signaling pathways in human airway epithelial cells

机译:活性氧通过人气道上皮细胞中的PKC-NADPH氧化酶-ROS-TGF-α信号通路调节铜绿假单胞菌脂多糖诱导的MUC5AC粘蛋白表达

获取原文
获取原文并翻译 | 示例
           

摘要

Mucin overproduction is a hallmark of chronic inflammatory airway diseases, such as asthma, chronic obstructive pulmonary disease, and cystic fibrosis. Excessive production of mucin leads to airway mucus obstruction and contributes to morbidity and mortality in these diseases. The molecular mechanisms underlying mucin overproduction, however, still remain largely unknown. Here, we report that the bacterium P. aeruginosa, an important human respiratory pathogen causing cystic fibrosis, utilizes reactive oxygen species (ROS) to up-regulate MUC5AC mucin expression. Pseudomonas aeruginosa lipopolysaccharide (PA-LPS) induces production of ROS through protein kinase C (PKC)-NADPH oxidase signaling pathway in human epithelial cells. Subsequently, ROS generation by PA-LPS releases transforming growth factor-alpha (TGF-alpha), which in turn, leads to up-regulate MUC5AC expression. These findings may bring new insights into the molecular pathogenesis of P. aeruginosa infections and lead to novel therapeutic intervention for inhibiting mucin overproduction in patients with P. aeruginosa infections. (c) 2007 Elsevier Inc. All rights reserved.
机译:粘蛋白过量生产是慢性炎性气道疾病的标志,例如哮喘,慢性阻塞性肺疾病和囊性纤维化。粘蛋白的过量生产导致气道粘液阻塞,并导致这些疾病的发病率和死亡率。然而,粘蛋白过量生产的分子机制仍然仍然是未知的。在这里,我们报告细菌铜绿假单胞菌,一种引起囊性纤维化的重要人类呼吸道病原体,利用活性氧(ROS)上调MUC5AC粘蛋白的表达。铜绿假单胞菌脂多糖(PA-LPS)通过人上皮细胞中的蛋白激酶C(PKC)-NADPH氧化酶信号传导途径诱导ROS的产生。随后,PA-LPS产生的ROS释放了转化生长因子-α(TGF-alpha),从而导致上调MUC5AC表达。这些发现可能为铜绿假单胞菌感染的分子发病机理带来新的见解,并导致抑制铜绿假单胞菌感染患者粘蛋白过量产生的新型治疗干预。 (c)2007 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号